Linda Burkly, Executive Vice President and Chief Scientific Officer at Editas Medicine, Inc. (), sold 4,928 shares of the company’s common stock on July 28, 2026. The shares were sold at a price of $2.67 per share, totaling approximately $13,157.
September 14, 2026
Trending
